Delavirdine Mesylate
-
Identifiers
CAS number
147221-93-0Molecular formula
C23H32N6O6S2SMILES
CC(C)NC1=C(N=CC=C1)N2CCN(CC2)C(=O)C3=CC4=C(N3)C=CC(=C4)NS(=O)(=O)C.CS(=O)(=O)O
Safety labels
Irritant -
Odor profile
Fragrance Odorless 69.39% Roasted 31.43% Savory 30.77% Cooked 30.22% Meaty 29.83% Popcorn 19.97% Cooling 19.07% Nutty 17.29% Burnt 17.24% Milky 16.55% Flavor Bitter 90.95% Odorless 32.56% Bland 24.33% Nitrile 19.08% Cedarleaf 18.65% Sweet-like 18.58% Very strong 18.14% Taco 17.79% Bread crust 17.78% Roasted peanuts 17.76% Odor impact est.
Odorless -
Properties
pKa est.
6.41 (neutral)Molecular weight
552.7 g/molVapor pressure est.
- hPa @ 20°C
- hPa @ 25°C
Evaporation rate
Ultra slowBoiling point est.
1705°CMelting point expt.
- MP: 226-228 °C /Delavirdine/
Flash point
- 354.19 ˚C est.
Solubility expt.
- In water: 2,942 mg/mL @ pH 1; 295 ug/mL @ pH 2; 0.81 ug/mL @ pH 7
-
Synonyms
- DELAVIRDINE MESYLATE
- 147221-93-0
- Delavirdine (mesylate)
- Delavirdine mesilate
- Rescriptor
- U-90152S
- delavirdine methanesulfonate
- Delavirdine monomethanesulfonate
- Delavirdine mesylate [USAN]
- UNII-421105KRQE
- CHEBI:4379
- Methanesulfonamide, N-[2-[[4-[3-[(1-methylethyl)amino]-2-pyridinyl]-1-piperazinyl]carbonyl]-1H-indol-5-yl]-, methanesulfonate (1:1)
- HSDB 7162
- 421105KRQE
- DRG-0166
- N-(2-(4-(3-(isopropylamino)pyridin-2-yl)piperazine-1-carbonyl)-1H-indol-5-yl)methanesulfonamide methanesulfonate
- U 90152E
- U 90152S
- U 90152T
- 1-(3-(Isopropylamino)-2-pyridyl)-4-((5-methanesulfonamidoindol-2-yl)carbonyl)piperazine monomethanesulfonate
- Delavirdine mesilate (JAN)
- Delavirdine mesylate (USAN)
- Piperazine, 1-(3-((1-methylethyl)amino)-2-pyridinyl)-4-((5-((methylsulfonyl)amino)-1H-indol-2-yl)carbonyl)-, monomethanesulfonate
- U 90152 (mesylate);BHAP-U 90152 (mesylate)
- DELAVIRDINE MESILATE [JAN]
- DELAVIRDINE MESILATE (MART.)
- DELAVIRDINE MESILATE [MART.]
- 1-(3-(ISOPROPYLAMINO)-2-PYRIDYL)-4-((5-METHANESULPHONAMIDOINDOL-2-YL)CARBONYL)PIPERAZINE MONOMETHANESULPHONATE
- PIPERAZINE, 1-(3-((1-METHYLETHYL)AMINO)-2-PYRIDINYL)-4-((5-((METHYLSULPHONYL)AMINO)-1H-INDOL-2-YL)CARBONYL)-, MONOMETHANESULPHONATE
- SR-05000001471
- Rescriptor (TN)
- 1-[3-(Isopropylamino)-2-pyridyl]-4-[(5-methanesulfonamidoindol-2-yl)carbonyl]piperazine monomethanesulfonate
- N-(2-((4-(3-(propan-2-ylamino)pyridin-2-yl)piperazin-1-yl)carbonyl)-1H-indol-5-yl)methanesulfonamide methanesulfonate
- N-[2-({4-[3-(propan-2-ylamino)pyridin-2-yl]piperazin-1-yl}carbonyl)-1H-indol-5-yl]methanesulfonamide methanesulfonate
- MFCD00866948
- Mesylate, Delavirdine
- CHEMBL929
- DELAVIRDINE, MESYLATE
- SCHEMBL40522
- DTXSID701017136
- DELAVIRDINE MESYLATE [HSDB]
- BCP09460
- DELAVIRDINE MESYLATE [VANDF]
- HY-10571A
- s6452
- DELAVIRDINE MESYLATE [WHO-DD]
- AKOS024458004
- AT12830
- CS-1661
- Delavirdine mesylate, >=98% (HPLC)
- FD20974
- DELAVIRDINE METHANESULFONATE [MI]
- AC-37638
- BS-15144
- DA-52421
- DELAVIRDINE MESYLATE [ORANGE BOOK]
- methanesulfonic acid;N-[2-[4-[3-(propan-2-ylamino)pyridin-2-yl]piperazine-1-carbonyl]-1H-indol-5-yl]methanesulfonamide
- N-[2-[[4-[3-[(1-Methylethyl)amino]-2-pyridinyl]-1-piperazinyl]carbonyl]-1H-indol-5-yl]methanesulfonamide mesylate
- U-90
- U-90152T
- C08087
- D00895
- SBI-0654139.0001
- EN300-19767275
- SR-05000001471-2
- Q27068164
- Z3243811539
- N-(2-(4-(3-(isopropylamino)pyridin-2-yl)piperazine-1-carbonyl)-1H-indol-5-yl)methanesulfonamidemethanesulfonate
- N-[2-(4-{3-[(propan-2-yl)amino]pyridin-2-yl}piperazine-1-carbonyl)-1H-indol-5-yl]methanesulfonamide; methanesulfonic acid
- N-[2-[[4-[3-[(1-Methylethyl)amino]-2-pyridinyl]-1-piperazinyl]carbonyl]-1H-indol-5-yl]methanesulfonamide methanesulfonate;U-90152S
- N-{2-[4-(3-Isopropylamino-pyridin-2-yl)-piperazine-1-carbonyl]-1H-indol-5-yl}-methanesulfonamide; compound with methanesulfonic acid
-
Applications
Delavirdine Mesylate (CAS 147221-93-0) is an active pharmaceutical ingredient (API) used in antiretroviral drug formulations; as the mesylate salt it improves solubility and oral bioavailability for NNRTI products. In pharmaceutical manufacturing, it is produced and formulated as a drug substance for NNRTI regimens. It also serves in medicinal chemistry research as a starting material and reference compound for NNRTI development and for analytical method development and quality control of related drugs. The salt form is commonly evaluated in formulation development to optimize solubility, stability, and handling, with use governed by local regulatory requirements.
gpt-5-nano
-
Solubility @25˚C
Solvent Solubility (g/L) ethanol 0.99 methanol 2.73 isopropanol 0.26 water 0.03 ethyl acetate 0.18 n-propanol 0.63 acetone 0.7 n-butanol 0.41 acetonitrile 0.3 DMF 6.15 toluene 0.03 isobutanol 0.29 1,4-dioxane 0.69 methyl acetate 0.44 THF 1.89 2-butanone 1.53 n-pentanol 0.37 sec-butanol 0.35 n-hexane 0.0 ethylene glycol 0.76 NMP 11.4 cyclohexane 0.0 DMSO 5.02 n-butyl acetate 0.26 n-octanol 0.2 chloroform 0.69 n-propyl acetate 0.31 acetic acid 2.76 dichloromethane 0.68 cyclohexanone 2.47 propylene glycol 1.21 isopropyl acetate 0.09 DMAc 14.26 2-ethoxyethanol 3.57 isopentanol 0.24 n-heptane 0.0 ethyl formate 1.16 1,2-dichloroethane 0.28 n-hexanol 0.13 2-methoxyethanol 7.49 isobutyl acetate 0.17 tetrachloromethane 0.04 n-pentyl acetate 0.46 transcutol 4.49 n-heptanol 0.23 ethylbenzene 0.02 MIBK 0.18 2-propoxyethanol 2.13 tert-butanol 0.09 MTBE 0.04 2-butoxyethanol 2.42 propionic acid 1.15 o-xylene 0.02 formic acid 6.39 diethyl ether 0.05 m-xylene 0.01 p-xylene 0.05 chlorobenzene 0.11 dimethyl carbonate 0.25 n-octane 0.0 formamide 6.99 cyclopentanone 3.87 2-pentanone 0.46 anisole 0.11 cyclopentyl methyl ether 0.11 gamma-butyrolactone 3.84 1-methoxy-2-propanol 2.08 pyridine 1.76 3-pentanone 0.3 furfural 7.18 n-dodecane 0.0 diethylene glycol 2.79 diisopropyl ether 0.01 tert-amyl alcohol 0.16 acetylacetone 0.55 n-hexadecane 0.0 acetophenone 0.43 methyl propionate 0.34 isopentyl acetate 0.23 trichloroethylene 1.0 n-nonanol 0.22 cyclohexanol 0.19 benzyl alcohol 0.57 2-ethylhexanol 0.07 isooctanol 0.15 dipropyl ether 0.05 1,2-dichlorobenzene 0.1 ethyl lactate 0.64 propylene carbonate 1.31 n-methylformamide 4.31 2-pentanol 0.08 n-pentane 0.0 1-propoxy-2-propanol 0.89 1-methoxy-2-propyl acetate 0.39 2-(2-methoxypropoxy) propanol 2.14 mesitylene 0.01 ε-caprolactone 2.07 p-cymene 0.02 epichlorohydrin 3.18 1,1,1-trichloroethane 0.09 2-aminoethanol 1.66 morpholine-4-carbaldehyde 7.89 sulfolane 5.63 2,2,4-trimethylpentane 0.0 2-methyltetrahydrofuran 0.51 n-hexyl acetate 0.42 isooctane 0.0 2-(2-butoxyethoxy)ethanol 3.02 sec-butyl acetate 0.12 tert-butyl acetate 0.07 decalin 0.0 glycerin 3.61 diglyme 4.19 acrylic acid 1.85 isopropyl myristate 0.12 n-butyric acid 1.16 acetyl acetate 0.13 di(2-ethylhexyl) phthalate 0.57 ethyl propionate 0.19 nitromethane 3.86 1,2-diethoxyethane 0.37 benzonitrile 0.6 trioctyl phosphate 0.25 1-bromopropane 0.08 gamma-valerolactone 13.31 n-decanol 0.14 triethyl phosphate 0.19 4-methyl-2-pentanol 0.04 propionitrile 0.33 vinylene carbonate 1.5 1,1,2-trichlorotrifluoroethane 6.45 DMS 0.29 cumene 0.01 2-octanol 0.13 2-hexanone 0.58 octyl acetate 0.26 limonene 0.02 1,2-dimethoxyethane 2.64 ethyl orthosilicate 0.14 tributyl phosphate 0.31 diacetone alcohol 0.52 N,N-dimethylaniline 0.08 acrylonitrile 0.83 aniline 0.2 1,3-propanediol 2.48 bromobenzene 0.06 dibromomethane 0.25 1,1,2,2-tetrachloroethane 0.71 2-methyl-cyclohexyl acetate 0.26 tetrabutyl urea 0.76 diisobutyl methanol 0.02 2-phenylethanol 0.39 styrene 0.03 dioctyl adipate 0.41 dimethyl sulfate 0.62 ethyl butyrate 0.21 methyl lactate 1.07 butyl lactate 1.18 diethyl carbonate 0.17 propanediol butyl ether 2.6 triethyl orthoformate 0.21 p-tert-butyltoluene 0.01 methyl 4-tert-butylbenzoate 0.63 morpholine 1.61 tert-butylamine 0.02 n-dodecanol 0.09 dimethoxymethane 0.96 ethylene carbonate 0.88 cyrene 3.63 2-ethoxyethyl acetate 1.02 2-ethylhexyl acetate 0.19 1,2,4-trichlorobenzene 0.18 4-methylpyridine 0.73 dibutyl ether 0.09 2,6-dimethyl-4-heptanol 0.02 DEF 1.06 dimethyl isosorbide 2.26 tetrachloroethylene 0.46 eugenol 1.53 triacetin 0.72 span 80 1.42 1,4-butanediol 1.11 1,1-dichloroethane 0.14 2-methyl-1-pentanol 0.29 methyl formate 2.57 2-methyl-1-butanol 0.33 n-decane 0.0 butyronitrile 0.35 3,7-dimethyl-1-octanol 0.11 1-chlorooctane 0.03 1-chlorotetradecane 0.01 n-nonane 0.0 undecane 0.0 tert-butylcyclohexane 0.0 cyclooctane 0.0 cyclopentanol 0.49 tetrahydropyran 0.3 tert-amyl methyl ether 0.05 2,5,8-trioxanonane 3.2 1-hexene 0.02 2-isopropoxyethanol 1.19 2,2,2-trifluoroethanol 1.35 methyl butyrate 0.49 Scent© AI
| Maximum acceptable concentrations in the finished product (%) | |||
|---|---|---|---|
|
Category 1
Products applied to the lips
|
No restriction |
Category 7A
Rinse-off products applied to the hair with some hand contact
|
No restriction |
|
Category 2
Products applied to the axillae
|
No restriction |
Category 7B
Leave-on products applied to the hair with some hand contact
|
No restriction |
|
Category 3
Products applied to the face/body using fingertips
|
No restriction |
Category 8
Products with significant anogenital exposure
|
No restriction |
|
Category 4
Products related to fine fragrance
|
No restriction |
Category 9
Products with body and hand exposure, primarily rinse off
|
No restriction |
|
Category 5A
Body lotion products applied to the body using the hands (palms), primarily leave on
|
No restriction |
Category 10A
Household care products with mostly hand contact
|
No restriction |
|
Category 5B
Face moisturizer products applied to the face using the hands (palms), primarily leave on
|
No restriction |
Category 10B
Household care products with mostly hand contact, including aerosol/spray products (with potential leave-on skin contact)
|
No restriction |
|
Category 5C
Hand cream products applied to the hands using the hands (palms), primarily leave on
|
No restriction |
Category 11A
Products with intended skin contact but minimal transfer of fragrance to skin from inert substrate without UV exposure
|
No restriction |
|
Category 5D
Baby Creams, baby Oils and baby talc
|
No restriction |
Category 11B
Products with intended skin contact but minimal transfer of fragrance to skin from inert substrate with potential UV exposure
|
No restriction |
|
Category 6
Products with oral and lip exposure
|
No restriction |
Category 12
Products not intended for direct skin contact, minimal or insignificant transfer to skin
|
No restriction |